Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
暂无分享,去创建一个
J. Blay | B. Bui | A. Le Cesne | I. Ray-Coquard | P. Viens | P. Berthaud | P. Kerbrat | D. Pérol | D. Cupissol | E. Bompas | F. Duffaud | S. Chabaud | J. Fayette | A. Adenis | M. Ríos | C. Delbaldo | C. Guillemet